Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
暂无分享,去创建一个
Jaehoon Chung | A. Reilhac | H. Shao | Yuan Chen | Yan Zhang | T. P. Loh | M. Stephenson | Yu Chen | Haitao Zhao | Christopher L H Chen | Carine Z. J. Lim | Nicholas R. Y. Ho
[1] Luke P. Lee,et al. Nanoplasmonic optical antennas for life sciences and medicine , 2018, Nature Reviews Materials.
[2] Alzheimer’s Association. 2018 Alzheimer's disease facts and figures , 2018, Alzheimer's & Dementia.
[3] C. Rowe,et al. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions , 2018, Nature Reviews Neurology.
[4] C. Rowe,et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease , 2018, Nature.
[5] P. Haydon,et al. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice , 2018, Molecular Neurodegeneration.
[6] Hakho Lee,et al. New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.
[7] Steven E. Arnold,et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.
[8] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[9] C. Théry,et al. Why the need and how to approach the functional diversity of extracellular vesicles , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.
[10] C. Masters,et al. A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain , 2017, Nature Reviews Neurology.
[11] C. Masters,et al. A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain , 2017, Nature Reviews Neurology.
[12] James G. Bollinger,et al. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis , 2017, Alzheimer's & Dementia.
[13] Lih-Fen Lue,et al. Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies , 2017, Neurology and Therapy.
[14] D. Teplow,et al. Pittsburgh Compound‐B (PiB) binds amyloid β‐protein protofibrils , 2017, Journal of neurochemistry.
[15] L. Tsai,et al. The road to restoring neural circuits for the treatment of Alzheimer's disease , 2016, Nature.
[16] K. Blennow,et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis , 2016, The Lancet Neurology.
[17] K. Blennow,et al. Plasma β-amyloid in Alzheimer’s disease and vascular disease , 2016, Scientific Reports.
[18] Melissa M. Sprachman,et al. SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions , 2016, Science.
[19] L. Schneider,et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.
[20] Bob S. Carter,et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma , 2015, Nature Communications.
[21] M. Heneka,et al. Innate immunity in Alzheimer's disease , 2015, Nature Immunology.
[22] N. Ferrara,et al. The emerging role of microRNAs in Alzheimer's disease , 2015, Front. Physiol..
[23] Y. Igarashi,et al. A potential function for neuronal exosomes: Sequestering intracerebral amyloid‐β peptide , 2015, FEBS letters.
[24] Reisa A. Sperling,et al. Alzheimer's disease , 2015, Nature Reviews Disease Primers.
[25] Magda Tsolaki,et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases , 2015, Nature Reviews Neurology.
[26] C. Théry,et al. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.
[27] Hakho Lee,et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor , 2014, Nature Biotechnology.
[28] Andrew F. Hill,et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.
[29] T. Nyman,et al. Isolation and characterization of platelet-derived extracellular vesicles , 2014, Journal of extracellular vesicles.
[30] Mary G. George,et al. Factors influencing the decline in stroke mortality: A statement for healthcare professionals from the American Heart Association/American Stroke Association , 2013 .
[31] Jung Hoon Jung,et al. Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo , 2013, Molecular Brain.
[32] Blaine R. Roberts,et al. Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization , 2013, PeerJ.
[33] Imre Mäger,et al. Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.
[34] Alexandre G. Brolo,et al. Plasmonics for future biosensors , 2012, Nature Photonics.
[35] Hakho Lee,et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy , 2012, Nature Medicine.
[36] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[37] B. Strooper,et al. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.
[38] S. Black,et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[39] Markus J Buehler,et al. Nanomechanics of functional and pathological amyloid materials. , 2011, Nature nanotechnology.
[40] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[41] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[42] Ezzie Hutchinson,et al. Systems neuroscience: The stress of dieting , 2011, Nature Reviews Neuroscience.
[43] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[44] Wendy R. Sanhai,et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.
[45] Asad Jan,et al. Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research , 2010, Nature Protocols.
[46] Prashant K. Jain,et al. Plasmonic coupling in noble metal nanostructures , 2010 .
[47] F. Hartl,et al. Converging concepts of protein folding in vitro and in vivo , 2009, Nature Structural &Molecular Biology.
[48] Robert L Moritz,et al. Exosomes: proteomic insights and diagnostic potential , 2009, Expert review of proteomics.
[49] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[50] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[51] P. Verkade,et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[52] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[53] P. Scheltens,et al. Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[54] L. K. Baker,et al. Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability* , 2002, The Journal of Biological Chemistry.
[55] S. Mazumdar,et al. Structural and conformational stability of horseradish peroxidase: effect of temperature and pH. , 2000, Biochemistry.
[56] J. L. La Montagne,et al. The Promise of New Technologies , 1994, International Journal of Technology Assessment in Health Care.